| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(99)00062-6 |
| P698 | PubMed publication ID | 10418898 |
| P50 | author | Kingston H Mills | Q45449153 |
| P2093 | author name string | L McCarthy | |
| A Moore | |||
| P2860 | cites work | Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes | Q72671221 |
| The instructive role of innate immunity in the acquired immune response | Q34375203 | ||
| Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon | Q34539973 | ||
| Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells | Q35532427 | ||
| Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function | Q36363597 | ||
| Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells. | Q38563231 | ||
| Cytokine cross-talk between phagocytic cells and lymphocytes: relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity | Q40810983 | ||
| The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer | Q41531913 | ||
| Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. | Q42062444 | ||
| Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. | Q44100288 | ||
| The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants | Q44479513 | ||
| A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection | Q45756786 | ||
| A rationale for the prophylactic use of monophosphoryl lipid A in sepsis and septic shock | Q50181049 | ||
| Immunogenicity and toxicity testing of an experimental HIV-1 vaccine in nonhuman primates | Q52072985 | ||
| Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. | Q55066427 | ||
| Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs | Q59059475 | ||
| Studies on the cellular site of action of the adjuvant activity of saponin for sheep erythrocytes | Q70214057 | ||
| Interleukin-12 production by human polymorphonuclear leukocytes | Q72508151 | ||
| P433 | issue | 20-21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2517-2527 | |
| P577 | publication date | 1999-06-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1 | |
| P478 | volume | 17 |
| Q39232080 | A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320. |
| Q74841572 | A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC) |
| Q35951545 | Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges |
| Q30407263 | An old enzyme for current needs: adenosine deaminase and a dendritic cell vaccine for HIV. |
| Q34030959 | Antigen-pulsed bone marrow-derived and pulmonary dendritic cells promote Th2 cell responses and immunopathology in lungs during the pathogenesis of murine Mycoplasma pneumonia |
| Q36685124 | Cathepsin-mediated necrosis controls the adaptive immune response by Th2 (T helper type 2)-associated adjuvants |
| Q33746872 | Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses |
| Q92765248 | Combining Monophosphoryl Lipid A (MPL), CpG Oligodeoxynucleotide (ODN), and QS-21 Adjuvants Induces Strong and Persistent Functional Antibodies and T Cell Responses against Cell-Traversal Protein for Ookinetes and Sporozoites (CelTOS) of Plasmodium |
| Q37712810 | Comparative analysis of Bacillus subtilis spores and monophosphoryl lipid A as adjuvants of protein-based mycobacterium tuberculosis-based vaccines: partial requirement for interleukin-17a for induction of protective immunity |
| Q59692337 | Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers |
| Q46546462 | Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis |
| Q64076203 | Enhanced Immunogenicity and Protective Efficacy of a Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21 |
| Q37344582 | Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo |
| Q36850638 | Fully Synthetic Self-Adjuvanting α-2,9-Oligosialic Acid Based Conjugate Vaccines against Group C Meningitis |
| Q35669044 | GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults |
| Q24806405 | Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity |
| Q28972540 | Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands |
| Q75325561 | Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor |
| Q42428380 | Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge |
| Q34307584 | Immunomodulators and delivery systems for vaccination by mucosal routes. |
| Q41702685 | Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance |
| Q34343245 | Manipulating the immune system: humoral versus cell-mediated immunity |
| Q34126807 | Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis |
| Q34981933 | Microbial/host interactions: mechanisms involved in host responses to microbial antigens |
| Q38727453 | Mucosal vaccine delivery: Current state and a pediatric perspective |
| Q36265526 | New age adjuvants and delivery systems for subunit vaccines |
| Q36974311 | Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system |
| Q81570162 | Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine |
| Q56447939 | QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans |
| Q37438261 | Rationale for peptide and DNA based epitope vaccines for Alzheimer's disease immunotherapy |
| Q37234723 | Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A. |
| Q34933694 | Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A |
| Q38803861 | STAT4 is required for the generation of Th1 and Th2, but not Th17 immune responses during monophosphoryl lipid A adjuvant activity |
| Q39412381 | Safety evaluation of a glutaraldehyde modified tyrosine adsorbed housedust mite extract containing monophosphoryl lipid A (MPL) adjuvant: a new allergy vaccine for dust mite allergy |
| Q91218696 | Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing |
| Q34400322 | TLR-based immune adjuvants. |
| Q37292481 | TLR4-dependent adjuvant activity of Neisseria meningitidis lipid A |
| Q45417025 | The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease. |
| Q73636790 | Therapeutic potential of protein and adjuvant vaccinations on tumour growth |
| Q51575029 | Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children. |
| Q97420836 | Toll-Like Receptor Ligand Based Adjuvant, PorB, Increases Antigen Deposition on Germinal Center Follicular Dendritic Cells While Enhancing the Follicular Dendritic Cells Network |
| Q26746644 | Toll-like receptors: the swiss army knife of immunity and vaccine development |
| Q38806558 | Vaccine technologies: From whole organisms to rationally designed protein assemblies |
Search more.